[Chemotherapy of opportunistic infections in AIDS].
Proposal for therapy and prophylaxis of opportunistic infections in AIDS using complex combinations consisting of four substances (Rifampicin + Sulfamethoxazol + Trimethoprim + Isoniazide or Rifampicin + Sulfamethoxazol + Trimethoprim + Protionamide) in a fixed combination.
Experimentelle Medizin, Forschungsinstituts Borstel.
E
E
Freerksen
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000328:Adult; D000900:Anti-Bacterial Agents; D000995:Antitubercular Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy*; D004359:Drug Therapy, Combination / Q000627:therapeutic use*; D006801:Humans; D009164:Mycobacterium Infections / Q000188:drug therapy*; D009165:Mycobacterium Infections, Nontuberculous / Q000188:drug therapy*; D009894:Opportunistic Infections / Q000188:drug therapy*; D014376:Tuberculosis / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D000995:Antitubercular Agents
Chemotherapie opportunistischer Infektionen bei AIDS.